Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
0(0%)
Results Posted
92%(11 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
13
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution13 total trials
N/ANon-phased studies
13(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(12)
Terminated(1)

Detailed Status

Completed12
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
92.3%
Most Advanced
N/A

Trials by Phase

N/A13 (100.0%)

Trials by Status

completed1292%
terminated18%

Recent Activity

Clinical Trials (13)

Drug Details

Intervention Type
DEVICE
Total Trials
13